Veraxa Biotech

Veraxa Biotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including antibody-drug conjugates (ADCs), bispecific T cell engagers (BiTAC TCEs), and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technologies.

Company Details

Employees
38
Founded
-
Address
Im Neuenheimer Feld 584, Heidelberg,baden-Württemberg 69120,germany
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Heidelberg, Baden-Württemberg
Looking for a particular Veraxa Biotech employee's phone or email?

Veraxa Biotech Questions

News

Duane Morris Represents Veraxa in $1.3 Billion SPAC Merger Agreement - Duane Morris LLP

Duane Morris Represents Veraxa in $1.3 Billion SPAC Merger Agreement Duane Morris LLP

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer - Yahoo Finance

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer Yahoo Finance

Revolutionary Cancer Treatment Platform Takes Center Stage as VERAXA Prepares for Major NASDAQ Debut - Stock Titan

Revolutionary Cancer Treatment Platform Takes Center Stage as VERAXA Prepares for Major NASDAQ Debut Stock Titan

VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology - The Manila Times

VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology The Manila Times

Swiss biotech firm Veraxa to list on Nasdaq in $1.64 billion SPAC deal - Reuters

Swiss biotech firm Veraxa to list on Nasdaq in $1.64 billion SPAC deal Reuters

Veraxa to go public in $1.6bn SPAC deal with Voyager - Pharmaceutical Technology

Veraxa to go public in $1.6bn SPAC deal with Voyager Pharmaceutical Technology

ZURICH - VERAXA Biotech files SEC registration for $1.3 billion SPAC merger - Investing.com

ZURICH - VERAXA Biotech files SEC registration for $1.3 billion SPAC merger Investing.com

Veraxa through a SPAC heads to Nasdaq - BioWorld MedTech

Veraxa through a SPAC heads to Nasdaq BioWorld MedTech

Top Veraxa Biotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant